Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Arthritis, Rheumatoid × Certolizumab Pegol × Clear all

Phase

Phase 4 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Crohn Disease 5 Lymphoma, Follicular 1 Fistula 1 Arthritis, Rheumatoid 1

Interventions

Methotrexate 4 Abatacept 3 tocilizumab 2 Rituximab 2 tofacitinib 1 secukinumab 1 olokizumab 1 golimumab 1 baricitinib 1 Radioimmunodetection 1 RC-18 1 Etanercept 1 Double-Blind Method 1 Certolizumab Pegol 1 Antirheumatic Agents 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01374971 2014-04-08

Rheumatoid Arthritis Treatment and Biopsy Study Assessing Certolizumab Pegol (Cimzia)

Arthritis Treatment Center, Maryland

Phase 3 Completed

12 enrolled 4 charts

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡